Showing results (31-40 of 587) with videos related to
Sort By:
Pageof 59
Journal of the American Geriatrics Society|July 1, 1986
Digitalis use in a retirement communityD D Schocken, B E Robinson, J Krug-Fite, et al.The Journal of Pharmacology and Experimental Therapeutics|August 1, 1997
Disposition of vessel dilator and long-acting natriuretic peptide in healthy humans after a one-hour infusionB H Ackerman, R M Overton, M T McCormick, et al.The Journal of Clinical Endocrinology and Metabolism|November 10, 2001
Atrial natriuretic hormone, vessel dilator, long-acting natriuretic hormone, and kaliuretic hormone decrease the circulating concentrations of total and tree T4 and free T3 with reciprocal increase in TSHD L Vesely, G I San Miguel, I Hassan, et al.Cardiovascular Research|February 17, 1998
Adrenomedullin, endothelin, neuropeptide Y, atrial, brain, and C-natriuretic prohormone peptides compared as early heart failure indicatorsS Daggubati, J R Parks, R M Overton, et al.Obesity Surgery|June 1, 1997
Body composition and source of weight loss after bariatric surgeryV Gahtan, S E Goode, H Z Kurto, et al.Metabolism: Clinical and Experimental|March 1, 1996
Atrial natriuretic peptides negatively and positively modulate circulating endothelin in humansD L Vesely, S Chiou, M A Douglass, et al.The Journal of Endocrinology|September 1, 1995
Kaliuretic peptide and long acting natriuretic peptide as well as atrial natriuretic factor inhibit aldosterone secretionD L Vesely, S Chiou, M A Douglass, et al.Life Sciences|January 1, 1996
Atrial natriuretic peptide increases adrenomedullin in the circulation of healthy humansD L Vesely, M Blankenship, M A Douglass, et al.The American Journal of the Medical Sciences|October 1, 1995
Atrial natriuretic peptides and cyclic guanosine monophosphate metabolismD L Vesely, A T Giordano, M A Douglass, et al.Annals of Epidemiology|August 26, 1998
Are sleep complaints an independent risk factor for myocardial infarction?S W Schwartz, J Cornoni-Huntley, S R Cole, et al.Pageof 59